FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Nephron Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved an original ANDA for ketorolac tromethamine from Nephron Pharmaceuticals Corporation, granting generic status for this NSAID.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Postoperative Pain

Drugs mentioned

• Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)